Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Meagan Spencer Barbee
Observed names:
Barbee, Meagan S.,
Meagan S Barbee,
Meagan S. Barbee
Institutions:
Emory Healthcare,
Emory University Hospital Midtown
Observed institutions:
Emory Healthcare,
Memorial Sloan Kettering Cancer Center,
Mercer University,
Emory University,
Emory University Hospital Midtown,
Winship Cancer Institute,
Atlanta Botanical Garden
show all 7
OpenAlex ID:
A5080905511
Current Status and Future Directions of the Immune Checkpoint Inhibitors Ipilimumab, Pembrolizumab, and Nivolumab in Oncology
2015
·
Meagan S. Barbee
, Adebayo Ogunniyi
, et al.
·
Annals of Pharmacotherapy
·
202
Pembrolizumab for the treatment of PD-L1 positive advanced or metastatic non-small cell lung cancer
2015
·
Thu Oanh Dang
, Adebayo Ogunniyi
, et al.
·
Expert Review of Anticancer Therapy
·
176
Subcutaneous Versus Intravenous Bortezomib: Efficiency Practice Variables and Patient Preferences
2013
·
Meagan S. Barbee
, R. Donald Harvey
, et al.
·
Annals of Pharmacotherapy
·
41
Taxanes: vesicants, irritants, or just irritating?
2013
·
Meagan S. Barbee
, Taofeek K. Owonikoko
, et al.
·
Therapeutic Advances in Medical Oncology
·
40
Comparison of rates of adherence to oral chemotherapy medications filled through an internal health-system specialty pharmacy vs external specialty pharmacies
2020
·
Colleen C McCabe
, Meagan S Barbee
, et al.
·
American Journal of Health-System Pharmacy
·
26
Safety and efficacy of extended dosing intervals of denosumab in patients with solid cancers and bone metastases: a retrospective study
2020
·
Aseala I. Abousaud
, Meagan S. Barbee
, et al.
·
Therapeutic Advances in Medical Oncology
·
13
PDF
Multidisciplinary Care of Adult Wilms’ Tumor During Pregnancy: A Case Report and Review of the Literature
2019
·
Jacqueline T. Brown
, Lara R. Harik
, et al.
·
Clinical Genitourinary Cancer
·
10
The clinical utility of strict laboratory monitoring of CDK 4/6 inhibitors in metastatic breast cancer patients.
2019
·
Urvi Patel
, Jane Lowe Meisel
, et al.
·
Journal of Clinical Oncology
·
1
Predictors of survival outcomes in phase 1 relapsed or refractory multiple myeloma patients
2014
·
Meagan S. Barbee
, Ajay Nooka
, et al.
·
Cancer
·
1
Gemcitabine with carboplatin in metastatic breast cancer: Characterizing outcomes in a modern, real-world population.
2020
·
Jordyn Paige Higgins
, Chloe Lalonde
, et al.
·
Journal of Clinical Oncology
Predictors Of Survival Outcomes In Phase I Relapsed Or Refractory Multiple Myeloma Patients
2013
·
R. Donald Harvey
, Meagan S. Barbee
, et al.
·
Blood
An evaluation of efficiency, safety, tolerability, patient satisfaction, and preference of subcutaneous (SQ) versus intravenous (IV) bortezomib (BTZ) administration in patients with multiple myeloma (MM).
2012
·
Meagan Spencer Barbee
, Nicole Maire Wilson
, et al.
·
Journal of Clinical Oncology
Show more works
View as search
Works count:
16
Citation count:
506
H-index:
7
I10-index:
6
Year
Topic
Type